U.S. federal trademark · Serial No. 75664422 · Reg. No. 2800564
Liposome encapsulated pharmaceuticals for use in the treatment of mascular degeneration, diabetic retinopathy, interstitial keratistis, cancer, malignant diseases, intraepithelial neoplasia, benign prostatic hyperplasia, Barrett's syndrome and coronary artery disease
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.